Table 1 Clinical and pathological information of thyroid cancer patients from FUSCC cohort enrolled in the study

From: Developing a thyroid cancer differentiation state classification system using deep residual networks and metabolic signature profiling

    

Group

 

Variable

Overall, N = 158a

PTC, N = 104a

FTC, N = 24a

PDTC, N = 19a

ATC, N = 11a

p-valueb

Age(year)

     

<0.001

 

45.92 (±16.25)

41.40 (±15.45)

51.04 (±12.58)

54.74 (±17.17)

62.27 (±8.90)

 

Gender

Female

94 (59.5%)

67 (64.4%)

16 (66.7%)

8 (42.1%)

3 (27.3%)

 

Male

64 (40.5%)

37 (35.6%)

8 (33.3%)

11 (57.9%)

8 (72.7%)

 

Tumor size (cm)

     

<0.001

 

3.52 (±1.97)

3.18 (±1.89)

3.46 (±1.74)

4.67 (±1.98)

4.76 (±2.22)

 

ETE

     

<0.001

True

71 (44.9%)

32 (30.8%)

12 (50.0%)

17 (89.5%)

10 (90.9%)

 

False

87 (55.1%)

72 (69.2%)

12 (50.0%)

2 (10.5%)

1 (9.1%)

 

ENE

     

<0.001

True

64 (40.5%)

34 (32.7%)

8 (33.3%)

15 (78.9%)

7 (63.6%)

 

False

94 (59.5%)

70 (67.3%)

16 (66.7%)

4 (21.1%)

4 (36.4%)

 

LNM.No

     

<0.001

 

6.80 (0–39)

5 (0–39)

1 (0–9)

1 (0–11)

1(0–30)

 

LNM.3 cm

True

21 (13.3%)

17 (16.3%)

1 (4.2%)

3 (15.8%)

1 (9.1%)

 

False

137 (86.7%)

87 (83.7%)

23 (95.8%)

16 (84.2%)

10 (90.9%)

 

T stage

     

<0.001

T1

35 (22.2%)

30 (28.8%)

4 (16.7%)

1 (5.3%)

0 (0)

 

T2

43 (27.2%)

33 (31.7%)

6 (25.0%)

2 (10.5%)

2 (18.2%)

 

T3

49 (31.0%)

29 (27.9%)

8 (33.3%)

8 (42.1%)

4 (36.4%)

 

T4

31 (19.6%)

12 (11.5%)

6 (25.0%)

8 (42.1%)

5 (45.5%)

 

N stage

N0

39 (24.7%)

14 (13.5%)

18 (75.0%)

4 (21.1%)

4 (36.4%)

 

N1

119 (75.3%)

90 (86.5%)

6 (15.0%)

15 (78.9%)

7 (64.6%)

 

M stage

     

<0.001

M0

119 (76.6%)

89 (85.5%)

17 (70.8%)

8 (42.1%)

5 (45.5%)

 

M1

39 (24.6%)

15 (14.5%)

7 (29.2%)

11 (57.9%)

6 (54.5%)

 

TNM stage

I

89 (56.4%)

76 (73.0%)

10 (41.7%)

3 (15.8%)

0 (0%)

 

II

34 (20.4%)

19 (18.3%)

6 (25.0%)

9 (47.4%)

0 (0%)

 

III

1 (0.6%)

1 (1.0%)

0 (0%)

0 (0%)

0 (0%)

 

IV

34 (22.6%)

8 (7.7%)

8 (33.3%)

7 (36.8%)

11 (100%)

 
  1. aMedian (IQR) or frequency (%).
  2. bKruskal–Wallis rank sum test; Fisher’s exact test.
Back to article page